241
Views
11
CrossRef citations to date
0
Altmetric
Original Investigations

Anxiety and depression are associated with long-term outcomes of hepatocellular carcinoma: A nationwide study of a cohort from Taiwan

, &
Pages 431-439 | Received 04 Jan 2016, Accepted 07 Dec 2016, Published online: 07 Mar 2017

References

  • Andersen BL, Yang HC, Farrar WB, Golden-Kreutz DM, Emery CF, Thornton LM, Young DC, Carson WE 3rd. 2008. Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial. Cancer. 113:3450–3458.
  • Austin PC, Ghali WA, Tu JV. 2003. A comparison of several regression models for analysing cost of CABG surgery. Stat Med. 22:2799–2815.
  • Bandelow B, Bauer M, Vieta E, El-Khalili N, Gustafsson U, Earley WR. 2014. Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline. World J Biol Psychiatry. 15:155–166.
  • Barber B, Dergousoff J, Slater L, Harris J, O'Connell D, El-Hakim H, Biron VL, Mitchell N, Seikaly H. 2016. Depression and survival in patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 142:284–288.
  • Costello EJ, Compton SN, Keeler G, Angold A. 2003. Relationships between poverty and psychopathology: a natural experiment. JAMA. 290:2023–2029.
  • DeFrances CJ, Lucas CA, Buie VC, Golosinskiy A. 2008. 2006 National Hospital Discharge Survey. Natl Health Stat Report. 5:1–20.
  • Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL Jr. 1983. The prevalence of psychiatric disorders among cancer patients. JAMA. 249:751–757.
  • Deyo RA, Cherkin DC, Ciol MA. 1992. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 45:613–619.
  • Dinkel A, Kremsreiter K, Marten-Mittag B, Lahmann C. 2014. Comorbidity of fear of progression and anxiety disorders in cancer patients. Gen Hosp Psychiatry. 36:613–619.
  • Efron B, Tibshirani R. 1993. An introduction to the Bootstrap. New York: Chapman & Hall.
  • Foley DL, Goldston DB, Costello EJ, Angold A. 2006. Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. Arch Gen Psychiatry. 63:1017–1024.
  • Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. 2011. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol. 29:413–420.
  • Huang KL, Su TP, Chen TJ, Chou YH, Bai YM. 2009. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study. Psychiatry Clin Neurosci. 63:401–409.
  • Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62:617–627.
  • Kunkel EJ, Kim JS, Hann HW, Oyesanmi O, Menefee LA, Field HL, Lartey PL, Myers RE. 2000. Depression in Korean immigrants with hepatitis B and related liver diseases. Psychosomatics. 41:472–480.
  • Manning WG, Mullahy J. 2001. Estimating log models: to transform or not to transform? J Health Econ. 20:461–494.
  • Marcus SC, Olfson M. 2010. National trends in the treatment for depression from 1998 to 2007. Arch Gen Psychiatry. 67:1265–1273.
  • Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. 2011. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 12:160–174.
  • Nardelli S, Pentassuglio I, Pasquale C, Ridola L, Moscucci F, Merli M, Mina C, Marianetti M, Fratino M, Izzo C, et al. 2013. Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQOL) in cirrhotic patients. Metab Brain Dis. 28:239–243.
  • Nemeroff CB. 2013. Psychoneuroimmunoendocrinology: the biological basis of mind-body physiology and pathophysiology. Depress Anxiety. 30:285–287.
  • Palmieri VO, Santovito D, Margari F, Lozupone M, Minerva F, Di Gennaro C, Todarello O, Palasciano G. 2015. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis. Clin Exp Med. 15:65–72.
  • Pan YJ, Knapp M, McCrone P. 2014. Impact of initial treatment outcome on long-term costs of depression: a 3-year nationwide follow-up study in Taiwan. Psychol Med. 44:1147–1158.
  • Popovic JR, Kozak LJ. 2000. National hospital discharge survey: annual summary, 1998. Vital Health Stat. 148:1–194.
  • Preljevic VT, Østhus TB, Os I, Sandvik L, Opjordsmoen S, Nordhus IH, Dammen T. 2013. Anxiety and depressive disorders in dialysis patients: association to health-related quality of life and mortality. Gen Hosp Psychiatry. 35:619–624.
  • Rosenbaum PR, Rubin DB. 1983. The central role of the propensity score in observational studies for causal effects. Biometrika. 70:41–55.
  • Satin JR, Linden W, Phillips MJ. 2009. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 115:5349–5361.
  • Schreiner A, Svensson A, Wapenaar R, Cherubin P, Princet P, Serazetdinova L, Zink M. 2014. Long-acting injectable risperidone and oral antipsychotics in patients with schizophrenia: results from a prospective, 1-year, non-interventional study (InORS). World J Biol Psychiatry. 15:534–545.
  • Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. 2002. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 20:3137–3148.
  • Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI. 2007. Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol. 25:2397–2405.
  • Townsend L, Walkup JT, Crystal S, Olfson M. 2012. A systematic review of validated methods for identifying depression using administrative data. Pharmacoepidemiol Drug Saf. 21:163–173.
  • Vin-Raviv N, Akinyemiju TF, Galea S, Bovbjerg DH. 2015. Depression and anxiety disorders among hospitalized women with breast cancer. PLoS One. 10:e0129169.
  • Waszczuk MA, Zavos HM, Gregory AM, Eley TC. 2014. The phenotypic and genetic structure of depression and anxiety disorder symptoms in childhood, adolescence, and young adulthood. JAMA Psychiatry. 71:905–916.
  • World Health Organization. 1989. The international classification of diseases, 9th revision. Clinical modification, 3rd ed. DHHS Publication No. (PHS) 89-1260. Washington, DC: Public Health Service, US Government Printing Office, March 1989.
  • Yang YL, Liu L, Wang Y, Wu H, Yang XS, Wang JN, Wang L. 2013. The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis. BMC Cancer. 13:393.
  • Yoon YH, Chen CM, Yi HY. 2014. Unintentional alcohol and drug poisoning in association with substance use disorders and mood and anxiety disorders: results from the 2010 Nationwide Inpatient Sample. Inj Prev. 20:21–28.
  • Zeger SL, Liang KY. 1986. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42:121–130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.